These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11342571)

  • 1. Cytokines and cellular interactions in inflammatory synovitis.
    Arend WP
    J Clin Invest; 2001 May; 107(9):1081-2. PubMed ID: 11342571
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent.
    Klimiuk PA; Yang H; Goronzy JJ; Weyand CM
    Clin Immunol; 1999 Jan; 90(1):65-78. PubMed ID: 9884354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokines in rheumatoid synovitis.
    Ziff M
    Recenti Prog Med; 1988; 79(7-8):318-22. PubMed ID: 3144029
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of interleukin-1 in bone resorption in rheumatoid arthritis.
    Strand V; Kavanaugh AF
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and the response to infection.
    van Deuren M; Dofferhoff AS; van der Meer JW
    J Pathol; 1992 Dec; 168(4):349-56. PubMed ID: 1484316
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.
    Xu G; Nie H; Li N; Zheng W; Zhang D; Feng G; Ni L; Xu R; Hong J; Zhang JZ
    J Clin Invest; 2005 Apr; 115(4):1060-7. PubMed ID: 15761492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
    Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
    Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial inflammation in rheumatoid arthritis.
    Harris ED
    Hosp Pract (Off Ed); 1986 Sep; 21(9):71-82. PubMed ID: 3091623
    [No Abstract]   [Full Text] [Related]  

  • 10. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
    J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis.
    Firestein GS
    J Clin Invest; 2004 Aug; 114(4):471-4. PubMed ID: 15314683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular IL-1 alpha in fibroblasts as a possible endogenous mediator of joint damage in rheumatoid arthritis.
    Apte RN
    Isr J Med Sci; 1997 Apr; 33(4):285-8. PubMed ID: 9347881
    [No Abstract]   [Full Text] [Related]  

  • 15. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
    Miossec P
    Arthritis Rheum; 2003 Mar; 48(3):594-601. PubMed ID: 12632409
    [No Abstract]   [Full Text] [Related]  

  • 17. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
    Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IL-1 receptor antagonist knockout mice].
    Horai R
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():55-8. PubMed ID: 15799318
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interleukin-1 in pathogenesis of rheumatoid arthritis].
    Iwakura Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():153-7. PubMed ID: 15799336
    [No Abstract]   [Full Text] [Related]  

  • 20. Review: Immune cells and mediators of inflammatory arthritis.
    Schett G
    Autoimmunity; 2008 Apr; 41(3):224-9. PubMed ID: 18365836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.